Clinical Trials
All Clinical Trials - Page 27 of 74
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT05035082Phase 4Completed
A Research Study Comparing RYBELSUS® to Other Blood Sugar Lowering Tablets in People Living in America With Type 2 Diabetes (REALYSE)
Semaglutide
- NCT04963712EARLY_Phase 1Completed
Zadaxin and HIV-positive Patients With Immune Reconstitution Disorder
Thymosin-Alpha-1
- NCT03891849N/AWithdrawn
Macro and Microcirculatory Effects of the Combination of Norepinephrine and Octreotide for the Treatment of Cirrhotic Patients With Hemorrhagic Shock
Octreotide
- NCT05023382N/ACompleted
A Study of Teduglutide in Japanese People With Short Bowel Syndrome
Teduglutide
- NCT05137145N/AUnknown
Effect and Safety of Polyethylene Glycol Combined With Linaclotide on Colon Cleansing for Patients With Chronic Constipation
Linaclotide
- NCT04532879N/AWithdrawn
HygiRelief Procedure and HygiSample Evaluation for Functional Constipation
Linaclotide
- NCT04964466N/AActive Not Recruiting
Release Kinetics in PRF Versus GEM21S With and Without Bone Substitutes: An In Vitro Analysis
Ghrp-6
- NCT04961996Phase 3Active Not Recruiting
A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer)
Gonadorelin
- NCT04624672Phase 4Terminated
Treatment of GLP-1 for Diabetic Bariatric Patients
Semaglutide
- NCT05203133N/ACompleted
Effects of Acute Energy Deficit and Aerobic Exercise on Muscle Quality
Ghrp-6
- NCT05029622Phase 3Completed
A Study to Assess the Efficacy and Safety of the Triptorelin 6-month Formulation in Paediatric Participants With Central Precocious Puberty.
Gonadorelin
- NCT04971785Phase 2Completed
Study of Semaglutide, and Cilofexor/Firsocostat, Alone and in Combination, in Adults With Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH)
Semaglutide
- NCT04862234Phase 4Terminated
Perioperative Stress Hyperglycemia in General and Vascular Surgery Patients
Dulaglutide
- NCT05046132Phase 4Completed
Study of Setmelanotide Effects on QTc (Corrected QT) Interval in Healthy Participants
Setmelanotide
- NCT04944992Phase 2Completed
A Study of Efinopegdutide (MK-6024) in Participants With Nonalcoholic Fatty Liver Disease (NAFLD) (MK-6024-001)
Semaglutide
- NCT04989348N/ACompleted
Euploid Rate of Blastocyst Derived From PPOS VS Antagonist Protocol
Gonadorelin
- NCT04982575Phase 2Completed
Research Study to Look at How Well Cagrilintide Together With Semaglutide Works in People With Type 2 Diabetes
Semaglutide
- NCT05220917N/AActive Not Recruiting
Comparative Effectiveness and Safety of Four Second Line Pharmacological Strategies in Type 2 Diabetes Study
Semaglutide
- NCT05003752Phase 1/Phase 2Active Not Recruiting
Hypo-Combi Trial: Hypofractionated EBRT Plus HDR-BT Boost for Prostate Cancer
Gonadorelin
- NCT04972175Phase 1Unknown
Safety and Efficacy of BC LisPram
Pramlintide
- NCT04741074Phase 3Terminated
Effect of Subcutaneous Semaglutide on Kidney Transplant Candidacy
Semaglutide
- NCT04946617N/AUnknown
Chlorhexidine and Essential Oil Mouthwashes on Human Beta-Defensin 2 (hbD2) and Kathelicidin (LL-37) Saliva Levels
Ll-37
- NCT05225974Phase 1Completed
A Randomized Phase 1 Study of Liralutide Injection in Healthy Chinese Subjects
Liraglutide
- NCT04731272Phase 2Recruiting
GLP-1 Agonist Therapy in Cystic Fibrosis-Related Glucose Intolerance
Dulaglutide
- NCT04740645N/ACompleted
NOCDURNA PASS Study Using Registries in Denmark, Germany and Sweden
Desmopressin
- NCT04940078Phase 1Completed
A Research Study to Compare Blood Levels of Cagrilintide and Semaglutide After Combined Versus Separate Injections in People With Overweight or Obesity
Semaglutide
- NCT04990024N/AUnknown
The Effect of Different Diets on Arterial Stiffness in Obese Patients on Semaglutide
Semaglutide
- NCT04901104N/ANot Yet Recruiting
Long-term Prognosis of Patients With Sepsis After Immunotherapy
Thymosin-Alpha-1
- NCT04787744Phase 2/Phase 3Recruiting
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
Gonadorelin
- NCT05073692N/ACompleted
Comparison of Type 2 Diabetes Pharmacotherapy Regimens
Liraglutide
- NCT04781998Phase 4Completed
Is Saxenda® a Viable Treatment of Obese Patients in Forensic Psychiatry?
Liraglutide
- NCT05161429N/AUnknown
BESTMED: Observational Evaluation of Second Line Therapy Medications in Diabetes
Semaglutide
- NCT04615910Phase 2Unknown
A GLP-1 Receptor PET Imaging Substudy Within the VER-A-T1D Trial Investigating the Effects on Beta Cell Mass
Exenatide
- NCT04974723N/ACompleted
Real-world Effectiveness and Cardiovascular Safety Study of Abaloparatide in Postmenopausal Women
Teriparatide
- NCT04048707Phase 2Withdrawn
Angiotensin 2 for Hepatorenal Syndrome
Octreotide
- NCT04941521Phase 1/Phase 2Completed
Exenatide for Treating Cocaine Use Disorder
Exenatide
- NCT04883346Phase 2Completed
Liraglutide (Saxenda(R)) in Adolescents With Obesity After Sleeve Gastrectomy
Liraglutide
- NCT06254235Phase 1Completed
Bioequivalence Study of Two Octreotide Microsphere Formulations in Healthy Volunteers
Octreotide
- NCT04871204Phase 2Completed
Octreotide Treatment to Improve Nutritional Recovery After Surgery for Patients with Esophageal or Gastric Cancer
Octreotide
- NCT05369013N/AUnknown
Study and Follow-up of the Clinical Effectiveness and Comparative Safety of Biosimilar Teriparatide in the Management of Postmenopausal or Senile.
Teriparatide
- NCT04903509Phase 1Completed
A Study in Men With Overweight to Test How Well Different Doses of BI 1820237 Are Tolerated When Given as an Injection Alone or in Combination With Liraglutide
Liraglutide
- NCT04904913Phase 2Completed
A Study of IBI362 Evaluating Weight Loss in Obese and Overweight Chinese Subjects
Mazdutide
- NCT04725240Phase 2Completed
Open-Label Study of Setmelanotide in Hypothalamic Obesity
Setmelanotide
- NCT04962503Phase 2Completed
A Proof of Concept Study to Evaluate the Safety of Afamelanotide in Patients With Acute Arterial Ischaemic Stroke (AIS)
Afamelanotide
- NCT04952779N/ACompleted
Regulatory Post Marketing Surveillance (rPMS) Study of Xultophy® (Insulin Degludec/Liraglutide) to Evaluate Safety and Effectiveness in Patients With Type 2 Diabetes Mellitus in Routine Clinical Practice in Korea
Liraglutide
- NCT04473989Phase 2Unknown
Weekly Use of Teriparatide to Accelerate Healing of Distal Radius Fracture
Teriparatide
- NCT04748042Phase 2Active Not Recruiting
Focal Radiation With Pulsed Systemic Therapy of Abiraterone, Androgen Deprivation Therapy (ADT), Lynparza Towards Castration Sensitive Oligometastatic Prostate Cancer (FAALCON)
Gonadorelin
- NCT04934722Phase 3Completed
Efficacy and Safety of Pembrolizumab (MK-3475) Plus Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus Enzalutamide Plus ADT in Participants With Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) (MK-3475-991/KEYNOTE-991)-China Extension
Gonadorelin
- NCT04823208Phase 1Completed
A Study of LY3437943 in Japanese Participants With Type 2 Diabetes Mellitus (T2DM)
Retatrutide
- NCT04921124Phase 3Completed
Pharmacokinetic and PHarmacodynamic Analysis and Evaluation of Teriparatide (PTH 1-34) Between Sexes
Teriparatide